Jerome Stevens Pharmaceuticals Announces Acquisition of Thyquidity® (Levothyroxine Sodium Oral Solution)
Jerome Stevens Pharmaceuticals, Inc., a US-based prescription pharmaceutical manufacturer and packager, has completed the acquisition of Thyquidity® (Levothyroxine Sodium Oral Solution) from Azurity Pharmaceuticals, Inc., a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the needs of overlooked patients.
